prevention of osteoporosis / treatment of osteoporosis / biologic license applications / /
MedicalCondition
osteoporosis / prostate cancer / MS / breast cancer / Postmenopausal Osteoporosis / /
Organization
Division of Reproductive and Urologic Drugs / Urologic Drugs / Advisory Committee for Reproductive Health Drugs / Columbia University / FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation / U.S. Food and Drug Administration / Division of Reproductive / Research Advisory Committee / /
Person
Kalyani Bhatt Designated / Theresa Kehoe / Catherine Stehman-Breen / Adrienne Rothstein / David Lacey / Paul Eisenberg / Vaishali Popat / Sandra Carson / George Benson / /
Position
Senior Vice President Global Regulatory Affairs / Medical Officer / DRUP Denosumab Safety Analysis / Chair / President / National Osteoporosis Foundation Discovery / Analyst / Clinical Team Leader / Vice President Global Development Amgen Inc Denosumab Pharmacovigilance Plan / Deputy Director / Federal Official / Senior Vice President Research Amgen Inc Denosumab Clinical Efficacy and Safety Assessments / /
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may